The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …

This comprehensive review provides an in-depth analysis of how nanotechnology has
revolutionized cancer theragnostic, which combines diagnostic and therapeutic methods to …

In the realm of gene therapy, a pivotal moment arrived with Paul Berg's groundbreaking
identification of the first recombinant DNA in 1972. This achievement set the stage for future …

Cancer has been classified as a diverse illness with a wide range of subgroups. Its early
identification and prognosis, which have become a requirement of cancer research, are …

This analysis explores the principal regulatory concerns linked to nanomedicines and gene
vaccines, including the complexities involved and the perspectives on how to navigate them …

Graphene quantum dots (GQDs) hold great promise for photodynamic and photothermal
cancer therapies. Their unique properties, such as exceptional photoluminescence …

Recently, carbon dots (CDs) have been actively studied and reported for their various
properties. In particular, the specific characteristics of carbon dots have been considered as …

In recent decades, quantum dots (QDs) with tunable bandgap, large absorption coefficient,
high quantum yield, multiexciton effect, and easy solution processing have unparalleled …

Primary brain cancer or brain cancer is the overgrowth of abnormal or malignant cells in the
brain or its nearby tissues that form unwanted masses called brain tumors. People with …

Cancer is not left with the space untouched, however, a complete cure has not been
achieved. Researchers are working extensively to bring a new edge to the treatment …